Parkinson's UK supports 99p Fitness pilot for communities in Northern Ireland
Date
News
Date
New research has advanced our understanding of a protein called alpha-synuclein, which is believed to play a central role in damaging brain cells in Parkinson’s.
Date
As Steve Ford prepares to step down, Shān brings extensive leadership experience from across the charity sector to Parkinson’s UK.
Date
Scientists in the UK have uncovered evidence that simple vision tests can predict who will develop Parkinson's dementia. And the evidence shows that a loss of wiring in the brain may be the cause.
Date
We’ve partnered with Alzheimer’s Society and University College London Hospitals (UCLH) Biomedical Research Centre. Together, we’ve developed a new resource to help lab-based researchers with patient and public involvement (PPI).
Date
Parkinson's didn't stop for coronavirus, and neither did we. Here are the three things we’re most proud of this year, and how you can get involved in 2021.
Date
Our 2020 volunteer award winners have been announced
Date
Our recent survey has found that nearly three quarters (74%) of people on Parkinson's medication experience 'wearing off', when symptoms including pain, stiffness and tremors become worse between doses.
Date
Parkinson’s UK is joining forces with US charity The Michael J. Fox Foundation and biopharma company Neurolixis to fund a £1.5m clinical trial of an exciting new drug to combat dyskinesia in people with Parkinson’s.
Date
After 15 years leading the charity, Steve Ford is saying a fond farewell to Parkinson's UK at the end of January 2021. He'll then start his search for a new challenge.
Date
Find out about a parliamentary committee we gave evidence to about the impact of coronavirus on people with Parkinson’s